IOL Chemicals to Host Q1 FY27 Earnings Call on August 13, 2026
IOL Chemicals and Pharmaceuticals Limited will hold an analyst/investor conference call on August 13, 2026, at 3:00 PM IST to discuss Q1 FY27 financial performance. Key management personnel will participate.
This is a standard procedural announcement regarding a conference call to discuss financial performance. It does not contain new financial data or significant business updates that would immediately impact the stock.
The announcement is a routine update about a scheduled conference call and does not contain financial results or forward-looking statements that would indicate a specific sentiment.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has announced that it will be organizing an analyst/investor conference call to discuss its financial performance for the quarter ended 30th June 2026.
The conference call is scheduled to take place on Thursday, 13th August 2026, at 3:00 PM IST. The call will feature management participants including Mr. Pardeep Kumar Khanna (Chief Financial Officer), Mr. Abhay Raj Singh (Sr. VP & Company Secretary), Mr. Kushal Kumar Rana (Director Works), and Mr. Rakesh Mahajan (Finance Advisor & Strategic Head).
Interested participants can pre-register for the call via a provided link. Dial-in details for India and international numbers, including Hong Kong, Singapore, USA, and UK, have also been shared. For RSVP and further inquiries, Ms. Prachi Ambre from MUFG Intime India Pvt. Ltd. can be contacted.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.